Lepu Medical Technology (Beijing) Co., Ltd., together with its subsidiaries, engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally. The company operates through three segments: Medical Devices; Pharmaceuticals; and Medical Services and Health Management. It offers medical devices, including cardiovascular devices, in vitro diagnostics, surgical instruments, peripheral blood vessels, blood purification, ultrasound imaging, and orthopedic products; pharmaceutical products for cardiovascular, digestive, central nervous, and respiratory systems, as well as antimicrobial, nutrition, traditional Chinese medicine, lowering blood sugar, and health food; and medical services and health management, such as medical services, AI, home appliances, and medical aesthetics and daily chemical products. The company is also involved in investment activities; trading; technological development; and pension services. It exports its products. The company was founded in 1999 and is based in Beijing, China.
Research context
Lepu Medical Technology (Beijing) Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Lepu Medical Technology (Beijing) Co., Ltd is currently in a long term downtrend where the price is trading 0.8% below its 200 day moving average.
From a valuation standpoint, the stock is 34.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.3.
Lepu Medical Technology (Beijing) Co., Ltd's total revenue rose by 12.2% to $2B since the same quarter in the previous year.
Its net income has increased by 636.1% to $833M since the same quarter in the previous year.
Finally, its free cash flow fell by 15.0% to $466M since the same quarter in the previous year.
Based on the above factors, Lepu Medical Technology (Beijing) Co., Ltd gets an overall score of 3/5.